Champions Oncology's (CSBR) CEO Ronnie Morris on Q3 2022 Results - Earnings Call Transcript

Mar. 16, 2022 10:56 AM ETChampions Oncology, Inc. (CSBR)
SA Transcripts profile picture
SA Transcripts

Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2022 Earnings Conference Call March 15, 2022 4:30 PM ET

Company Participants

Ronnie Morris – Chief Executive Officer

David Miller – Chief Financial Officer

Conference Call Participants

Matt Hewitt – Craig-Hallum Capital Group


Good afternoon, ladies and gentlemen, and welcome to the Champions Oncology Third Quarter Fiscal Year 2022 Earnings Call. At this time, all participants have been placed on a listen-only mode. And we will open the floor for your questions and comments after the presentation.

It is now my pleasure to turn the floor over to your host, Dr. Ronnie Morris, CEO of Champions Oncology. Sir, the floor is yours.

Ronnie Morris

Good afternoon. I’m Ronnie Morris, CEO of Champions Oncology. Joining me today is David Miller, our Chief Financial Officer. Thank you for joining us for our quarterly earnings call. Before I begin, I will remind you that we will be making forward-looking statements during today's call and that actual results could differ materially from what is described in those statements. Additional information on factors that could cause results to differ is available in our Form 10-Q and Form 10-K.

A reconciliation of non-GAAP financial measures that may be discussed during the call to GAAP financial measures is available in the earnings release.

Overall, we had another great quarter in which we had record revenue and record bookings as we continue to execute on our plans for growth. As discussed on our year-end call, we presented our transformative strategic vision for the next several years, highlighting the uniqueness of our TumorBank and related data. I indicated that we will continue to grow our existing oncology research services business while also expanding into new high value opportunities that leverages our data and platform, which would affect our longer-term growth.

While executing on

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.